文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

对以下内容的修正：流感融合膜糖蛋白血凝素2（HA2）亚基与溶瘤新城疫病毒之间的协同作用抑制肿瘤生长，并通过免疫检查点PD-1阻断进一步增强。

Correction to: Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade.

作者信息

Miri Seyed Mohammad, Ebrahimzadeh Mir Saeed, Abdolalipour Elahe, Yazdi Mahsa, Ravandi Hassan Hosseini, Ghaemi Amir

机构信息

Department of Virology, Pasteur Institute of Iran, Tehran, Iran.

Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

Cancer Cell Int. 2020 Oct 28;20:522. doi: 10.1186/s12935-020-01610-3. eCollection 2020.

DOI:10.1186/s12935-020-01610-3
PMID:33132759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7594438/
Abstract

[This corrects the article DOI: 10.1186/s12935-020-01476-5.].

摘要

[本文更正了文章的数字对象标识符：10.1186/s12935-020-01476-5。]

相似文献

[1]
Correction to: Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade.

Cancer Cell Int. 2020-10-28

[2]
Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade.

Cancer Cell Int. 2020-8-7

[3]
The final conformation of the complete ectodomain of the HA2 subunit of influenza hemagglutinin can by itself drive low pH-dependent fusion.

J Biol Chem. 2011-2-3

[4]
Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.

J Virol. 2015-10

[5]
Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment.

Mol Ther. 2021-5-5

[6]
Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes.

Mucosal Immunol. 2015-1

[7]
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.

J Immunother Cancer. 2019-8-10

[8]
Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection.

Arch Virol. 2015-3

[9]
Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin.

Antiviral Res. 2012-10-2

[10]
Contributions of HA1 and HA2 Subunits of Highly Pathogenic Avian Influenza Virus in Induction of Neutralizing Antibodies and Protection in Chickens.

Front Microbiol. 2020-6-5

引用本文的文献

[1]
Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.

Front Immunol. 2021

本文引用的文献

[1]
Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade.

Cancer Cell Int. 2020-8-7

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索